1 |
metastatic renal cell carcinoma
(1854 times)
|
Neoplasms (1085 times)
|
OS (609 times) PFS (516 times) CI (203 times)
|
1992 Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies.
|
2 |
metastatic RCC
(144 times)
|
Neoplasms (72 times)
|
RCC (128 times) OS (26 times) PFS (20 times)
|
2002 Therapeutic options in the management of renal cell carcinoma.
|
3 |
metastatic clear cell renal cell carcinoma
(18 times)
|
Neoplasms (10 times)
|
TKI (4 times) VEGF (4 times) PFS (3 times)
|
2009 The medical management of metastatic renal cell carcinoma: integrating new guidelines and recommendations.
|
4 |
metastatic clear cell renal cancer
(6 times)
|
Neoplasms (4 times)
|
VEGF (3 times) HR (2 times) OS (2 times)
|
2011 Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
|
5 |
metastatic renal cell carcinoma patients
(2 times)
|
Pharmacokinetics (1 time)
|
NLR (2 times) OS (2 times) DBP (1 time)
|
2017 A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.
|
6 |
murine renal cell carcinoma
(2 times)
|
Neoplasms (2 times)
|
G250-FMLs (1 time) MLs (1 time) RCC (1 time)
|
2001 Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes.
|
7 |
metastatic kidney cancer
(1 time)
|
Health Services (1 time)
|
AEs (1 time) DI (1 time) mDI (1 time)
|
2022 Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
|
8 |
metastatic primary ccRCCs
(1 time)
|
Neoplasms (1 time)
|
ccRCC (1 time) nmRCC (1 time)
|
2016 Opposite prognostic roles of HIF1alpha and HIF2alpha expressions in bone metastatic clear cell renal cell cancer.
|
9 |
metastatic renal cell carcinoma with clear cell component
(1 time)
|
Neoplasms (1 time)
|
Ave-Axi (1 time) Ipi-Nivo (1 time) OS (1 time)
|
2020 Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.
|
10 |
multilocular RCC
(1 time)
|
Neoplasms (1 time)
|
ccRCC (1 time) chRCC (1 time) FoxM1 (1 time)
|
2015 Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
|